ArticleThe Lancet regional health. Western Pacific2025
Changing age profile and incidence of injecting drug use initiation among people in Australia who inject drugs: evidence from two national repeated cross-sectional studies.
Article in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Intranasal Mucosal Atomiser Devices: A Novel Harm Reduction Intervention.Drug and alcohol review · 2026Article
- An age-period-cohort-interaction analysis of meth/amphetamine-related deaths in Australia, 2001-2020.Addiction (Abingdon, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The age of people who inject drugs appears to be increasing in some high-income countries. We aimed to explore trends in the age of people injecting and recently starting to inject drugs in Australia, and to model incidence of initiation over time. Methods: We obtained data from the Illicit Drug Reporting System (IDRS) and the Australian Needle Syringe Program Survey (ANSPS), which comprise annual cross-sectional surveys with people who inject drugs (2000-2019). Outcome measures were current age, age of initiation, and time since initiation (both surveys), and drug first injected (IDRS only). We estimated time trends in age using quantile regression. We used the relative number of people initiating injecting drug use each year and existing population size estimates to model incidence of initiation. Findings: In total, 58,465 interviews with people who reported injecting drugs in the past month (33.7% women) were included. In both surveys, the median age increased over the study period (IDRS: 28-43 years; ANSPS 28-44 years). The median time since initiation also increased over the study period (IDRS: 8-22.5 years; ANSPS: 9-24 years), and the median age of initiation increased with calendar year of initiation (IDRS: 18-34 years; ANSPS: 20-30 years). Women tended to be younger and commence injecting drug use at a younger age than men. Modelling suggested that similar numbers of people injected drugs for the first time each year from 1980 (national estimates of 15,570 and 17,020 new initiates using IDRS and ANSPS data, respectively) to 1996 (IDRS: 16,360; ANSPS: 22,300 new initiates), followed by a decisive decline in incidence until 2012 (IDRS: 1110; ANSPS: 1830), whereafter it has fluctuated but remained low. Meth/amphetamine was consistently the predominant drug injected at initiation among IDRS participants, although there were peaks in heroin as the drug injected at initiation in the early 1980s and mid-1990s. Interpretation: In 2019, most people who were injecting drugs in Australia were part of a cohort that began injecting in the 1980s or 1990s. Consequently, the population was older and had been injecting drugs for longer compared to those injecting drugs in 2000. This has implications for health service delivery to people who inject drugs, with increasing age likely to be accompanied by a rise in chronic health conditions and an increase in injecting duration potentially resulting in higher incidence of injecting-related injuries and diseases. Funding: Australian Government Department of Health and Aged Care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.